Archive

Year: 2017

  • FleishmanHillard Named to PRNews’ CSR A-List for Fifth Straight Year

    ST. LOUIS, February 3, 2017 — FleishmanHillard has been named a finalist on this year’s CSR A-List, presented by PRNews. This is the fifth consecutive year that the agency has made the list, which recognizes those companies who are leaders in CSR best practices. The CSR Awards also honor the top CSR campaigns and initiatives of the year, as well as the communications professionals behind them. Finalists will be honored at PRNews’ Spring Award Luncheon on March 22, 2017, in Washington, D.C.

  • FleishmanHillard’s Andrea Margolin Named to PRNews’ 2017 Top Women in PR

    ST. LOUIS, January 25, 2017 — FleishmanHillard’s Andrea Margolin has been named to this year’s Top Women in PR list, presented by PRNews. The annual list recognized women who are not only at the top of their fields in PR and communications, but who serve as leaders that inspire the next generation of female PR professionals. Margolin helps lead the social and innovation team in the agency’s Atlanta office, and has more then 12 years of public relations experience. Honorees were recognized at a ceremony in New York City on January 24, 2017.

  • Tech Minute: Machine Learning, Bots, and Cognitive Web Services – Oh My!

    by Don Moxley Could they be the “great and powerful Oz” for brand marketers? It was recently announced that Estée Lauder is the first major retailer to launch a Facebook Messenger bot service. Using artificial intelligence, the bot provides holiday shoppers with gift ideas and a 60-minute delivery service all from the comfort of Messenger. Many similar bots have been announced by brands in the last year. As a developer working for a marketing firm, this got me thinking. If we can go to Facebook Messenger for immediate Christmas gift delivery, what other brand marketing opportunities are now within reach?...

  • New Year, New Administration, New FDA and New Cures: Approvals and Enforcement Outlook for 2017

    by Mark Senak Every U.S. federal agency is facing the potential for considerable change given a new Administration taking office this month, setting into motion the process whereby new heads of bureaucracies assume responsibility and bring different priorities and agendas to their respective roles. But one – the Food and Drug Administration – which regulates one-fifth of the U.S. economy – is also facing the implementation of sweeping new legislation – the 21st Century Cures Act (Cures) passed into law late last year. That single fact alone makes the choice of a new FDA Commissioner all the more important and...

  • 7 Food Trends for 2017

    by Ashley Capps From sriracha to smoothie bowls, food trends evolve quickly as chefs and consumers look for the “next big thing.” After sifting through reports from Mintel, Bon Appétit and Iconoculture, we found two overarching themes that are a good temperature check of what’s on the hearts and plates of Americans today: 1) Americans are turning to comfort in familiar flavors; 2) they are looking to make the world a better place through innovation. From the FleishmanHillard food, agriculture & beverage (FAB) team, here are the food trends coming to a menu near you in 2017: George Jetson’s Meal...

  • Four Reasons Why Obamacare Won’t Be Repealed In Trump’s First 100 Days

    How Will Healthcare Fare in Trump’s First 100 Days? Ever since Franklin Roosevelt succeeded Herbert Hoover in the White House, the nation has focused tremendous attention on a new president’s first 100 days. As Donald J. Trump prepares to take office, national attention will turn again to the first 100 days to see how the new president tries to steer the ship of state while he has the wind at his back. We have seen presidents as different as George W. Bush and Barack Obama use their first 100 days to make fairly dramatic changes in economic and social policy...

  • These are Three Storylines We’re Watching at the J.P. Morgan Healthcare Conference

    by Adam Silverstein It’s that time of year again. We’re days away from the annual J.P. Morgan Healthcare Conference in San Francisco. All eyes will be on this gathering of the world’s biotechnology start-ups, pharmaceutical companies, medical device manufacturers, and health insurers. And it means that what company leaders say and the stories they tell media and investors, is incredibly important. A muddled message, no matter how small, can have big consequences.  This year, we’ll be paying extra attention to which companies tell exceptional stories at the conference. Who will have a message that’s clear and resonates, no matter how...

NEWER